Literature DB >> 7925446

Peptide substrate specificity and properties of the zinc-endopeptidase activity of botulinum type B neurotoxin.

C C Shone1, A K Roberts.   

Abstract

Clostridium botulinum type B neurotoxin has been shown to be a zinc endopeptidase specific for vesicle-associated membrane protein (VAMP). A synthetic peptide of human/rat VAMP-2 [VAMP-2-(60-94)] is cleaved by the neurotoxin with the same specificity as that demonstrated for the membrane-associated protein (at the Gln76-Phe77 bond) and has been used to study the properties of the endopeptidase activity of the neurotoxin. Cleavage of the VAMP-2 peptide was demonstrated by both botulinum type B neurotoxin (Km = 3.3 x 10(-4) M) and by its purified light subunit (Km = 3.5 x 10(-4) M). The endopeptidase displayed a pH optimum of 7.0-7.5 and was inhibited by greater than 0.2 M NaCl and greater than 0.05 M sodium phosphate. Neurotoxin which had been inactivated by dialysis against EDTA could be re-activated by incubation with various divalent cations, notably Zn2+ and Cu2+. The substrate specificity of botulinum type B neurotoxin was studied using various analogues of VAMP-2 (60-94). The neurotoxin cleaved selectively to the N-terminal side of phenylalanine and tyrosine; no activity was observed with either leucine, valine or alanine in the P'1 position. The properties of the P1 amino acid were less critical; the neurotoxin cleaving the C-terminus of glutamine, asparagine and alanine. A substrate analogue with valine in the P1 position corresponding to the sequence of rat VAMP-1 was not cleaved. The rate of cleavage of a substrate analogue representing the sequence of human VAMP-1, however, was more than twofold that of the VAMP-2 peptide. The properties and substrate specificity of botulinum type B neurotoxin suggest that the toxin represents a novel class of endopeptidase which requires a specific peptide substrate conformation for the expression of proteolytic activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925446     DOI: 10.1111/j.1432-1033.1994.00263.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  31 in total

1.  Development of an in vitro bioassay for Clostridium botulinum type B neurotoxin in foods that is more sensitive than the mouse bioassay.

Authors:  M Wictome; K Newton; K Jameson; B Hallis; P Dunnigan; E Mackay; S Clarke; R Taylor; J Gaze; K Foster; C Shone
Journal:  Appl Environ Microbiol       Date:  1999-09       Impact factor: 4.792

2.  A capillary electrophoresis technique for evaluating botulinum neurotoxin B light chain activity.

Authors:  Michael Adler; Harlan F Shafer; Heather A Manley; Brennie E Hackley; James D Nicholson; James E Keller; Michael C Goodnough
Journal:  J Protein Chem       Date:  2003-07

3.  Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: Evidence for noncanonical zinc protease activity.

Authors:  Brent Segelke; Mark Knapp; Saloumeh Kadkhodayan; Rod Balhorn; Bernhard Rupp
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-23       Impact factor: 11.205

4.  Synaptic vesicle chips to assay botulinum neurotoxins.

Authors:  Géraldine Ferracci; Raymond Miquelis; Shunji Kozaki; Michael Seagar; Christian Lévêque
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

Review 5.  Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting.

Authors:  B R Singh
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

6.  A yeast assay probes the interaction between botulinum neurotoxin serotype B and its SNARE substrate.

Authors:  Hong Fang; Wentian Luo; Jim Henkel; Joseph Barbieri; Neil Green
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

7.  Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities.

Authors:  B Hallis; B A James; C C Shone
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

8.  Proteolysis of synthetic peptides by type A botulinum neurotoxin.

Authors:  J J Schmidt; K A Bostian
Journal:  J Protein Chem       Date:  1995-11

9.  Isolation and quantification of botulinum neurotoxin from complex matrices using the BoTest matrix assays.

Authors:  F Mark Dunning; Timothy M Piazza; Füsûn N Zeytin; Ward C Tucker
Journal:  J Vis Exp       Date:  2014-03-03       Impact factor: 1.355

10.  Potent new small-molecule inhibitor of botulinum neurotoxin serotype A endopeptidase developed by synthesis-based computer-aided molecular design.

Authors:  Yuan-Ping Pang; Anuradha Vummenthala; Rajesh K Mishra; Jewn Giew Park; Shaohua Wang; Jon Davis; Charles B Millard; James J Schmidt
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.